rs4252668

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_002393.5(MDM4):​c.-101T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00739 in 152,284 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0074 ( 8 hom., cov: 32)
Exomes 𝑓: 0.010 ( 0 hom. )

Consequence

MDM4
NM_002393.5 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.618

Publications

12 publications found
Variant links:
Genes affected
MDM4 (HGNC:6974): (MDM4 regulator of p53) This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus, and shows structural similarity to p53-binding protein MDM2. Both proteins bind the p53 tumor suppressor protein and inhibit its activity, and have been shown to be overexpressed in a variety of human cancers. However, unlike MDM2 which degrades p53, this protein inhibits p53 by binding its transcriptional activation domain. This protein also interacts with MDM2 protein via the RING finger domain, and inhibits the latter's degradation. So this protein can reverse MDM2-targeted degradation of p53, while maintaining suppression of p53 transactivation and apoptotic functions. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2011]
MDM4 Gene-Disease associations (from GenCC):
  • bone marrow failure syndrome 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS2
High AC in GnomAd4 at 1124 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MDM4NM_002393.5 linkc.-101T>C 5_prime_UTR_variant Exon 1 of 11 ENST00000367182.8 NP_002384.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MDM4ENST00000367182.8 linkc.-101T>C 5_prime_UTR_variant Exon 1 of 11 1 NM_002393.5 ENSP00000356150.3

Frequencies

GnomAD3 genomes
AF:
0.00738
AC:
1123
AN:
152068
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00249
Gnomad AMI
AF:
0.0308
Gnomad AMR
AF:
0.00681
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.0182
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00981
Gnomad OTH
AF:
0.00718
GnomAD4 exome
AF:
0.0102
AC:
1
AN:
98
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
76
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
10
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0122
AC:
1
AN:
82
Other (OTH)
AF:
0.00
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00739
AC:
1124
AN:
152186
Hom.:
8
Cov.:
32
AF XY:
0.00804
AC XY:
598
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00243
AC:
101
AN:
41532
American (AMR)
AF:
0.00680
AC:
104
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4820
European-Finnish (FIN)
AF:
0.0182
AC:
193
AN:
10604
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00981
AC:
667
AN:
67994
Other (OTH)
AF:
0.00853
AC:
18
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00942
Hom.:
1
Bravo
AF:
0.00635
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.8
DANN
Benign
0.49
PhyloP100
-0.62
PromoterAI
-0.15
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252668; hg19: chr1-204485572; API